Alphonse Breast Cancer Foundation Challenges Facebook users to a $10 Challenge on Giving Tuesday On Giving Tuesday on December 3rd, 2019, Facebook is matching a total of up to $7 million in donations made on Facebook to eligible US-based 501(c)(3) nonprofits. And Alphonse Breast Cancer Foundation is eligible! So with our wonderful active Facebook …
Alphonse Breast Cancer Foundation Challenges Facebook users Read More »
A study by an international group of researchers has found for the first time that a combination of immunotherapy and chemotherapy can extend lives of women with triple-negative breast cancer. A new treatment option would be significant because triple-negative breast cancers don’t respond to hormone therapy or targeted therapy. In addition, they tend to grow and spread faster than …
Study Supports Immunotherapy for Treating Triple-Negative Breast Cancer Read More »
An important way to keep up with your breast health is to be aware of how your breasts normally look and feel, and know what changes to look for. Finding breast cancer as early as possible gives you a better chance of successful treatment. But knowing what to look for is not a substitute for screening …
Study compares Kadcyla (T-DM1) to Herceptin (Trastuzumab) Research presented at the San Antonio Breast Cancer Symposium may result in a new standard of care for some people with HER2 positive, early stage breast cancer. Typically, patients treated with a combination of chemotherapy and Herceptin (trastuzumab) who still have some breast cancer remaining at the time of surgery are given more Herceptin afterward. …
New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer Read More »
Although there is no sure way to prevent breast cancer, there are several things you can do that may lower your likelihood of getting it. Other factors, including family history, also increase your risk, but most women who get breast cancer (about 8 out of 10) do not have it in the family. Here are 5 ways to …
If you’re preparing for chemotherapy for the first time, you may be wondering what to expect. We asked our Facebook community to share their best advice for preparing for chemotherapy – and the side effects that come with it. Here’s what they had to say. Get some rest Fatigue is the most common side effect experienced by cancer patients, especially those undergoing …
10 Chemotherapy Tips From Cancer Patients Who’ve Been There Read More »
Cancer survivors are more likely than people with no cancer history to have money-related problems due to medical bills according to a study published in CANCER, a peer-reviewed journal of the American Cancer Society. The study, published January 21, 2019, says younger survivors faced the greatest financial difficulties. And among survivors with private insurance, those enrolled in high …
Cancer Survivors Face Significant Financial Problems Read More »
A research study identified new genes that may be associated with a higher risk for triple negative breast cancer. Out of 100 people with breast cancer about 15 will have triple-negative breast cancer (TNBC). It’s one of the most challenging types of breast cancer to treat due to several things: TNBC tends to be more …
Study: New Genes Linked With Triple Negative Breast Cancer Read More »
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor. It’s specifically for advanced breast cancer patients – postmenopausal women and men – whose tumors have the PIK3CA mutation and are hormone receptor (HR) …
FDA Approves First PI3K Inhibitor for Breast Cancer Read More »
A mammogram is an important step in taking care of yourself and your breasts. A mammogram is a low-dose x-ray that allows specialists to look for changes in breast tissue that aren’t normal. The American Cancer Society recommends that women at average risk of breast cancer – most women – should begin having yearly mammograms at age 45, and can change …
